Fulcrum Therapeutics, Inc. — All Filings
468 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
3
4
4/A
424B4
424B5
5
8-A12B
8-K
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DEFR14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
POS AM
POS EX
POSASR
PRE 14A
S-1
S-1/A
S-3
S-3ASR
S-3MEF
S-8
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0001576419-25-000745 | Apr 17, 2025 | — |
| 8-K | 8-K | 0000950170-25-032355 | Mar 4, 2025 | Feb 26, 2025 |
| 8-K | 8-K | 0000950170-25-026063 | Feb 25, 2025 | — |
| 10-K | 10-K | 0000950170-25-026068 | Feb 25, 2025 | Dec 31, 2024 |
| S-8 | S-8 | 0001193125-25-034249 | Feb 25, 2025 | — |
| SCHEDULE 13G | — | 0000902664-25-000860 | Feb 12, 2025 | — |
| 4 | 4 | 0000950170-25-009818 | Jan 28, 2025 | Jan 24, 2025 |
| 4 | 4 | 0000950170-25-009816 | Jan 28, 2025 | Jan 24, 2025 |
| 4 | 4 | 0000950170-25-009813 | Jan 28, 2025 | Jan 24, 2025 |
| 4 | 4 | 0000950170-25-009815 | Jan 28, 2025 | Jan 24, 2025 |
| 8-K | 8-K | 0001193125-25-004942 | Jan 13, 2025 | — |
| SCHEDULE 13G | — | 0000919574-25-000110 | Jan 6, 2025 | — |
| 8-K | 8-K | 0001193125-24-284214 | Dec 23, 2024 | Dec 18, 2024 |
| SC 13G | — | 0002012383-24-004535 | Dec 6, 2024 | — |
| SC 13G/A | — | 0000919574-24-006744 | Nov 14, 2024 | — |
| 4 | 4 | 0000950170-24-127074 | Nov 14, 2024 | Nov 12, 2024 |
| SCHEDULE 13G | — | 0001104659-24-119151 | Nov 14, 2024 | — |
| 3 | 3 | 0000950170-24-127055 | Nov 14, 2024 | Nov 12, 2024 |
| SC 13G/A | FULCRUM THERAPEUTICS, INC. | 0000902664-24-006487 | Nov 14, 2024 | — |
| 8-K | 8-K | 0000950170-24-125927 | Nov 13, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-125931 | Nov 13, 2024 | Sep 30, 2024 |
| SC 13G/A | — | 0000932471-24-001033 | Nov 12, 2024 | — |
| 8-K | 8-K | 0001193125-24-256101 | Nov 12, 2024 | — |
| SC 13G | — | 0002012383-24-003431 | Nov 8, 2024 | — |
| SC 13G/A | — | 0000932471-24-000432 | Nov 4, 2024 | — |
| SC 13G | — | 0002012383-24-000922 | Oct 21, 2024 | — |
| SC 13G/A | — | 0000315066-24-002025 | Oct 7, 2024 | — |
| 8-K | 8-K | 0000950170-24-109069 | Sep 24, 2024 | — |
| 3 | — | 0001415889-24-023836 | Sep 23, 2024 | Sep 12, 2024 |
| SC 13G | SC 13G | 0001193125-24-222915 | Sep 20, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-100319 | Sep 16, 2024 | — |
| 8-K | 8-K | 0001193125-24-217822 | Sep 12, 2024 | — |
| 4 | — | 0001415889-24-022127 | Aug 23, 2024 | Aug 21, 2024 |
| SC 13G/A | SC 13G/A | 0001104659-24-092442 | Aug 23, 2024 | — |
| 8-K | 8-K | 0001193125-24-205347 | Aug 22, 2024 | Aug 21, 2024 |
| 8-K | 8-K | 0000950170-24-088236 | Jul 31, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-088238 | Jul 31, 2024 | Jun 30, 2024 |
| S-8 | S-8 | 0001193125-24-189503 | Jul 31, 2024 | — |
| 4 | 4 | 0000950170-24-081949 | Jul 8, 2024 | Jul 3, 2024 |
| 4 | 4 | 0000950170-24-074868 | Jun 18, 2024 | Jun 17, 2024 |
| 4 | 4 | 0000950170-24-074885 | Jun 18, 2024 | Jun 17, 2024 |
| 3 | 3 | 0000950170-24-074855 | Jun 18, 2024 | Jun 17, 2024 |
| 4 | 4 | 0000950170-24-074887 | Jun 18, 2024 | Jun 17, 2024 |
| 4 | 4 | 0000950170-24-074882 | Jun 18, 2024 | Jun 17, 2024 |
| 4 | 4 | 0000950170-24-074883 | Jun 18, 2024 | Jun 17, 2024 |
| 4 | 4 | 0000950170-24-074884 | Jun 18, 2024 | Jun 17, 2024 |
| 4 | 4 | 0000950170-24-074888 | Jun 18, 2024 | Jun 17, 2024 |
| 4 | 4 | 0000950170-24-074892 | Jun 18, 2024 | Jun 17, 2024 |
| 8-K | 8-K | 0001193125-24-162653 | Jun 17, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-058193 | May 13, 2024 | Mar 31, 2024 |